Pathstone Family Office, LLC Abiomed Inc Transaction History

Pathstone Family Office, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 23, 2023	BUY	$242.49 - $301.46 $468,005 - $581,817	1,930 New	1,930 $474,000
Q3 2022 Nov 14, 2022	BUY	$242.49 - $301.46 $272,558 - $338,841	1,124 Added 132.7%	1,971 $485,000
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $190,346 - $286,828	847 New	847 $210,000
Q1 2021 May 14, 2021	SELL	$285.92 - $355.13 $14,867 - $18,466	-52 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$251.88 - $324.2 $13,097 - $16,858	52 New	52 $17,000
Q2 2019 Aug 14, 2019	SELL	$250.96 - $284.94 $48,435 - $54,993	-193 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $1,381 - $1,811	5 Added 2.66%	193 $54,000
Q4 2018 Feb 14, 2019	BUY	$281.08 - $444.25 $52,843 - $83,519	188 New	188 $61,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.